MRNY
YieldMax MRNA Option Income Strategy ETF·Financial Services
17.89
1.269%(−0.23)
Market ClosedLast Updated: — ET
52W L: $13.6052W H: $27.50
YieldMax MRNA Option Income Strategy ETF·Financial Services
Market Peers
YieldMax MRNA Option Income Strategy ETF (MRNY) is maintained as a Sell due to heightened downside risk and overvalued pipeline optimism. MRNY's aggressive 100% covered call strategy captures some upside but offers limited downside protection and lower income in flat markets. Moderna's (MRNA) revenue base is structurally declining, with oncology pipeline progress already priced into an elevated EV/revenue multiple.
CHICAGO and MILWAUKEE and NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- YieldMax® ETFs today announced distributions for the YieldMax® Group 2 weekly pay ETFs. Group 2 Distribution Announcement Ex.
About a month into the new year, exchange-traded funds (ETFs) are beginning to build up enough of a performance record for 2026 to potentially differentiate themselves from the broader market. The funds with the best track record in 2026 may surprise some investors.
Stock News Amazon trims 16,000 roles: Amazon (AMZN) will eliminate about 16,000 positions as part of ongoing restructuring, offering most U.S. staff 90 days for
YieldMax MRNA Option Income Strategy ETF has rebounded sharply from historic lows, driven by positive catalysts in underlying Moderna. MRNY's distributions have increased alongside MRNA's share price resurgence, demonstrating the ETF's alignment with its underlying performance. Recent MRNA catalysts include partnership rumors, better-than-expected Q3 2025 revenue, EMA COVID shot approval, and promising cancer therapy trial results.
CHICAGO and MILWAUKEE and NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- YieldMax® ETFs today announced distributions for the YieldMax® Group 2 weekly pay ETFs. Group 2 Distribution Announcement Ex.
